SEC Form 4 · accession 0001209191-18-027116
Eloxx Pharmaceuticals, Inc. · ELOX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gilad Shabtai
10% Owner
Period of report
Apr 30, 2018
Accepted (ET)
May 1, 2018 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001035354
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 30, 2018 | P | 75,000 | $9.75 | A | 3,351,770 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the purchase of shares in the follow-on offering of Common Stock of Eloxx Pharmaceuticals, Inc. that closed on April 30, 2018.